Results 131 to 140 of about 240,839 (324)

Identification of exon skipping events associated with Alzheimer’s disease in the human hippocampus

open access: yesBMC Medical Genomics, 2019
At least 90% of human genes are alternatively spliced. Alternative splicing has an important function regulating gene expression and miss-splicing can contribute to risk for human diseases, including Alzheimer’s disease (AD).
Seonggyun Han   +7 more
semanticscholar   +1 more source

A gene-edited mouse model of limb-girdle muscular dystrophy 2C for testing exon skipping

open access: yesDisease Models & Mechanisms, 2019
Limb-girdle muscular dystrophy type 2C is caused by autosomal recessive mutations in the γ-sarcoglycan (SGCG) gene. The most common SGCG mutation is a single nucleotide deletion from a stretch of five thymine residues in SGCG exon 6 (521ΔT). This founder
A. Demonbreun   +8 more
semanticscholar   +1 more source

CD44 alternative splicing is a sensor of intragenic DNA methylation in tumors [PDF]

open access: yesarXiv, 2019
DNA methylation (meDNA) is a suspected modulator of alternative splicing, while splicing in turn is involved in tumour formations nearly as frequently as DNA mutations. Yet, the impact of meDNA on tumorigenesis via its effect on splicing has not been thoroughly explored. Here, we find that HCT116 colon carcinoma cells inactivated for the DNA methylases
arxiv  

Multiple Exon Skipping in the Duchenne Muscular Dystrophy Hot Spots: Prospects and Challenges

open access: yesJournal of Personalized Medicine, 2018
Duchenne muscular dystrophy (DMD), a fatal X-linked recessive disorder, is caused mostly by frame-disrupting, out-of-frame deletions in the dystrophin (DMD) gene. Antisense oligonucleotide-mediated exon skipping is a promising therapy for DMD.
Y. Echigoya   +3 more
semanticscholar   +1 more source

Deleterious c-Cbl Exon Skipping Contributes to Human Glioma

open access: yesNeoplasia: An International Journal for Oncology Research, 2015
c-Cbl, a RING-type ubiquitin E3 ligase, downregulates various receptor tyrosine kinases (e.g., epidermal growth factor receptor (EGFR)), leading to inhibition of cell proliferation.
Min Woo Seong   +10 more
doaj   +1 more source

A Machine Learning Strategy to Identity Exonic Splice Enhancers in Human Protein-coding Sequence [PDF]

open access: yesarXiv, 2004
Background: Exonic splice enhancers are sequences embedded within exons which promote and regulate the splicing of the transcript in which they are located. A class of exonic splice enhancers are the SR proteins, which are thought to mediate interactions between splicing factors bound to the 5' and 3' splice sites.
arxiv  

A Gene Prediction Method Based on Statistics and Signal Processing [PDF]

open access: yesarXiv, 2014
Bioinformatics, as an emerging and rapidly developing interdisciplinary, has become a promising and popular research field in 21st century. Extracting and explaining useful biological information from huge amount of genetic data is an urgent issue in post-genome era. In eukaryotic DNA sequences, gene consists of exons and introns.
arxiv  

AON-Mediated Exon Skipping to Bypass Protein Truncation in Retinal Dystrophies Due to the Recurrent CEP290 c.4723A > T Mutation. Fact or Fiction?

open access: yesGenes, 2019
Mutations in CEP290 encoding a centrosomal protein important to cilia formation cause a spectrum of diseases, from isolated retinal dystrophies to multivisceral and sometimes embryo–lethal ciliopathies.
Iris Barny   +8 more
semanticscholar   +1 more source

Co-occurring Alterations in the RAS–MAPK Pathway Limit Response to MET Inhibitor Treatment in MET Exon 14 Skipping Mutation-Positive Lung Cancer

open access: yesClinical Cancer Research, 2019
Purpose: Although patients with advanced-stage non–small cell lung cancers (NSCLC) harboring MET exon 14 skipping mutations (METex14) often benefit from MET tyrosine kinase inhibitor (TKI) treatment, clinical benefit is limited by primary and acquired ...
J. Rotow   +24 more
semanticscholar   +1 more source

Identification of Novel Antisense-Mediated Exon Skipping Targets in DYSF for Therapeutic Treatment of Dysferlinopathy

open access: yesMolecular Therapy: Nucleic Acids, 2018
Dysferlinopathy is a progressive myopathy caused by mutations in the dysferlin (DYSF) gene. Dysferlin protein plays a major role in plasma-membrane resealing.
Joshua J.A. Lee   +4 more
doaj  

Home - About - Disclaimer - Privacy